Medical Technology

@xconomy.com 4 years ago

Five Years After Y Combinator First Admits Biotechs, They’re Dug In

@techcrunch.com 5 years ago

Bios raises $4.5M to further develop its ‘neural interface’ and new ways to treat chronic medical conditions

@xconomy.com 5 years ago

With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?

@techcrunch.com 6 years ago

Doctolib raises another $42 million for its medical care scheduling service